Annual Secretarial Compliance Report for the year ended 31st March, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eiko Lifesciences has filed its Annual Secretarial Compliance Report for the financial year ended 31 March 2025, as required under SEBI LODR Regulation 24A. The report was certified by Practicing Company Secretary Shravan A. Gupta after reviewing the company's filings, website, records, and compliance with SEBI regulations. The company has marked compliance as 'Yes' across all 12 parameters, including Secretarial Standards, policy adoption and updates, website disclosures, director disqualification, preservation of documents, board performance evaluation, related party transactions, event disclosures, and insider trading rules. No actions were taken by SEBI or stock exchanges against the company, and no additional non-compliances were observed. An additional compliance certificate confirms that the Structured Digital Database (SDD) required under Insider Trading Regulations is properly maintained with audit trails.
This is a routine annual compliance filing and carries no material impact on the stock price. The clean compliance report, with no observations or penalties, reassures shareholders that the company is meeting all SEBI listing and disclosure requirements.